Last updated on August 2016

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone ) on the Clearance of Verruca Vulgaris (Common Warts)


Brief description of study

Warts are benign epidermal tumors caused by human papillomaviruses (HPVs). The active pharmaceutical ingredient DPCP has been used for many years as a compounded formulation in acetone for the treatment of warts, alopecia areata and more recently, cutaneous metastatic melanoma lesions. An improved topical ointment formulation of DPCP called Samcyprone™ will be evaluated for the treatment of common warts.

Clinical Study Identifier: NCT02640820

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Director Clinical Operations

International Dermatology Research
Miami, FL United States
  Connect »

Director Clinical Operations

Summit Dermatology
Oakbrook Terrace, IL United States
  Connect »

Director Clinical Operations

Dawes Fretzin Clinical Research Group
Indianapolis, IN United States
  Connect »

Director Clinical Operations

Mount Sinai - St. Luke's
New York City, NY United States
  Connect »